The risk of human papillomavirus infection for male fertility abnormality: a meta-analysis

Yi-Quan Xiong, Yan-Xia Chen, Ming-Ji Cheng, Wen-Qiao He, Qing Chen, Yi-Quan Xiong, Yan-Xia Chen, Ming-Ji Cheng, Wen-Qiao He, Qing Chen

Abstract

Human papillomavirus (HPV) is the most common sexually transmitted virus in males and females worldwide; yet its impact upon male fertility remains unclear. The objective of this study was to evaluate the potential impact of HPV infection in semen on male fertility abnormality. A systematic literature search was performed in PubMed, Medline, Embase, Web of Science, and the Cochrane Library database for relevant publications up to May 6, 2017. The odds ratio (OR), and its corresponding 95% confidence interval (CI), was selected to represent the effect size. Statistical analysis was conducted using STATA 12.0. In total, eight articles, providing data on 1955 participants, were included in this meta-analysis. Collectively, the data suggested that HPV infection of semen was a risk factor for male fertility abnormality with an OR of 3.02 (95% CI: 2.11-4.32; I2 = 6.9%). Sensitivity analysis revealed that the results of this study were robust. In conclusion, HPV infection of semen represents a risk factor for male fertility abnormality.

Keywords: human papillomavirus; male infertility; meta-analysis; semen infection.

Conflict of interest statement

All authors declared no competing interests

Figures

Figure 1
Figure 1
Flow diagram of the studies identified in the meta-analysis. CI: confidence interval; OR: odds ratio; HPV: Human papillomavirus.
Figure 2
Figure 2
The risk of human papillomavirus semen infection for male fertility abnormality. CI: confidence interval; OR: odds ratio.
Figure 3
Figure 3
Sensitivity analysis of the risk of human papillomavirus semen infection for male infertility. CI: confidence interval.

References

    1. Thoma ME, McLain AC, Louis JF, King RB, Trumble AC, et al. Prevalence of infertility in the United States as estimated by the current duration approach and a traditional constructed approach. Fertil Steril. 2013;99:1324–31.e1.
    1. Szkodziak P, Wozniak S, Czuczwar P, Wozniakowska E, Milart P, et al. Infertility in the light of new scientific reports – Focus on male factor. Ann Agric Environ Med. 2016;23:227–30.
    1. Pellati D, Mylonakis I, Bertoloni G, Fiore C, Andrisani A, et al. Genital tract infections and infertility. Eur J Obstet Gynecol Reprod Biol. 2008;140:3–11.
    1. Bezold G, Politch JA, Kiviat NB, Kuypers JM, Wolff H, et al. Prevalence of sexually transmissible pathogens in semen from asymptomatic male infertility patients with and without leukocytospermia. Fertil Steril. 2007;87:1087–97.
    1. Conde-Ferraez L, Chan May Ade A, Carrillo-Martinez JR, Ayora-Talavera G, Gonzalez-Losa Mdel R. Human papillomavirus infection and spontaneous abortion: a case-control study performed in Mexico. Eur J Obstet Gynecol Reprod Biol. 2013;170:468–73.
    1. Skoczynski M, Gozdzicka-Jozefiak A, Kwasniewska A. Prevalence of human papillomavirus in spontaneously aborted products of conception. Acta Obstet Gynecol Scand. 2011;90:1402–5.
    1. Ticconi C, Pietropolli A, Fabbri G, Capogna MV, Perno CF, et al. Recurrent miscarriage and cervical human papillomavirus infection. Am J Reprod Immunol. 2013;70:343–6.
    1. Souho T, Benlemlih M, Bennani B. Human papillomavirus infection and fertility alteration: a systematic review. PloS One. 2015;10:e0126936.
    1. Giuliano AR, Nielson CM, Flores R, Dunne EF, Abrahamsen M, et al. The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study. J Infect Dis. 2007;196:1146–52.
    1. Garolla A, Pizzol D, Foresta C. The role of human papillomavirus on sperm function. Curr Opin Obstet Gynecol. 2011;23:232–7.
    1. Rintala MA, Pollanen PP, Nikkanen VP, Grenman SE, Syrjanen SM. Human papillomavirus DNA is found in the vas deferens. J Infect Dis. 2002;185:1664–7.
    1. Giovannelli L, Migliore MC, Capra G, Caleca MP, Bellavia C, et al. Penile, urethral, and seminal sampling for diagnosis of human papillomavirus infection in men. J Clin Microbiol. 2007;45:248–51.
    1. Foresta C, Noventa M, De Toni L, Gizzo S, Garolla A. HPV-DNA sperm infection and infertility: from a systematic literature review to a possible clinical management proposal. Andrology. 2015;3:163–73.
    1. Schillaci R, Capra G, Bellavia C, Ruvolo G, Scazzone C, et al. Detection of oncogenic human papillomavirus genotypes on spermatozoa from male partners of infertile couples. Fertil Steril. 2013;100:1236–40.
    1. Laprise C, Trottier H, Monnier P, Coutlee F, Mayrand MH. Prevalence of human papillomaviruses in semen: a systematic review and meta-analysis. Hum Reprod. 2014;29:640–51.
    1. Garolla A, Lenzi A, Palu G, Pizzol D, Bertoldo A, et al. Human papillomavirus sperm infection and assisted reproduction: a dangerous hazard with a possible safe solution. Hum Reprod. 2012;27:967–73.
    1. Rintala MA, Grenman SE, Pollanen PP, Suominen JJ, Syrjanen SM. Detection of high-risk HPV DNA in semen and its association with the quality of semen. Int J STD AIDS. 2004;15:740–3.
    1. Lee CA, Huang CT, King A, Chan PJ. Differential effects of human papillomavirus DNA types on p53 tumor-suppressor gene apoptosis in sperm. Gynecol Oncol. 2002;85:511–6.
    1. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
    1. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–5.
    1. Wells GA, Shea B, O’Connell D, Peterson J, Welch V, et al. The Newcastle. Ottawa Scale (NOS) for Assessing the Quality if Nonrandomized Studies in Meta. Analyses. 2009. [Last accessed on 2018 Jan 21]. Available from: .
    1. Rostom A, Dube C, Cranney A, Saloojee N, Richmond Sy, et al. Celiac Disease. Rockville (MD): Agency for Healthcare Research and Quality (US), (Evidence Reports/Technology Assessments, No. 104.) 2004. [Last accessed on 2018 Jan 21]. Available from: .
    1. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.
    1. Yang Y, Jia CW, Ma YM, Zhou LY, Wang SY. Correlation between HPV sperm infection and male infertility. Asian J Androl. 2013;15:529–32.
    1. Foresta C, Pizzol D, Moretti A, Barzon L, Palu G, et al. Clinical and prognostic significance of human papillomavirus DNA in the sperm or exfoliated cells of infertile patients and subjects with risk factors. Fertil Steril. 2010;94:1723–7.
    1. Kumar K, Deka D, Singh A, Chattopadhyay P, Dada R. Expression pattern of PRM2, HSP90 and WNT5A in male partners of couples experiencing idiopathic recurrent miscarriages. J Genet. 2012;91:363–6.
    1. Rohde V, Erles K, Sattler HP, Derouet H, Wullich B, et al. Detection of adeno-associated virus in human semen: does viral infection play a role in the pathogenesis of male infertility? Fertil Steril. 1999;72:814–6.
    1. La Vignera S, Vicari E, Condorelli RA, Franchina C, Scalia G, et al. Prevalence of human papilloma virus infection in patients with male accessory gland infection. Reprod Biomed Online. 2015;30:385–91.
    1. Garolla A, Engl B, Pizzol D, Ghezzi M, Bertoldo A, et al. Spontaneous fertility and in vitro fertilization outcome: new evidence of human papillomavirus sperm infection. Fertil Steril. 2016;105:65–72.e1.
    1. Cortés-Gutiérrez EI, Dávila-Rodríguez MI, Fernández JL, de la O-Pérez LO, Garza-Flores ME, et al. The presence of human papillomavirus in semen does not affect the integrity of sperm DNA. Andrologia. 2017;49:e12774.
    1. Caliskan T, Kocak I, Kirdar S, Serter M, Okyay P, et al. Human papilloma virus and Chlamydia trochomatis in asymptomatic Turkish men: prevalence and relation among semen parameters and IL-18 levels. Eur Urol Suppl. 2008;7:156.
    1. Foresta C, Garolla A, Parisi S, Ghezzi M, Bertoldo A, et al. HPV prophylactic vaccination in males improves the clearance of semen infection. EBioMedicine. 2015;2:1487–93.
    1. Garolla A, Pizzol D, Bertoldo A, De Toni L, Barzon L, et al. Association, prevalence, and clearance of human papillomavirus and antisperm antibodies in infected semen samples from infertile patients. Fertil Steril. 2013;99:125–31.
    1. Garolla A, Pizzol D, Ghezzi M, Selice R, Bertoldo A, et al. Prevalence and clearance of human papillomavirus in semen samples of infertile patients and role on sperm parameters. Hum Reprod. 2013;28:32.
    1. Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, et al. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology. 2010;401:70–9.
    1. Oborna I, Ondryasova H, Zborilova B, Brezinova J, Vrbkova J. Does presence of human papillomavirus (HPV) infection influence the results of in vitro fertilization (IVF) treatment? Fertil Steril. 2016;106:e335–6.
    1. Tanaka H, Karube A, Kodama H, Fukuda J, Tanaka T. Mass screening for human papillomavirus type 16 infection in infertile couples. J Reprod Med. 2000;45:907–11.
    1. Yang R, Wang Y, Qiao J, Liu P, Geng L, et al. Does human papillomavirus infection do harm to in vitro fertilization outcomes and subsequent pregnancy outcomes? Chin Med J (Engl) 2013;126:683–7.
    1. Comar M, Monasta L, Zanotta N, Vecchi Brumatti L, Ricci G, et al. Human papillomavirus infection is associated with decreased levels of GM-CSF in cervico-vaginal fluid of infected women. J Clin Virol. 2013;58:479–81.
    1. Perino A, Giovannelli L, Schillaci R, Ruvolo G, Fiorentino FP, et al. Human papillomavirus infection in couples undergoing in vitro fertilization procedures: impact on reproductive outcomes. Fertil Steril. 2011;95:1845–8.
    1. Capra G, Nyitray AG, Lu B, Perino A, Marci R, et al. Analysis of persistence of human papillomavirus infection in men evaluated by sampling multiple genital sites. Eur Rev Med Pharmacol Sci. 2015;19:4153–63.
    1. Fode M, Fusco F, Lipshultz L, Weidner W. Sexually transmitted disease and male infertility: a systematic review. Eur Urol Focus. 2016;2:383–93.
    1. Giakoumelou S, Wheelhouse N, Cuschieri K, Entrican G, Howie SE, et al. The role of infection in miscarriage. Hum Reprod Update. 2016;22:116–33.
    1. Rompalo A. Preventing sexually transmitted infections: back to basics. J Clin Invest. 2011;121:4580–3.
    1. Huang QT, Zhong M, Gao YF, Huang LP, Huang Q, et al. Can HPV vaccine have other health benefits more than cancer prevention?. A systematic review of association between cervical HPV infection and preterm birth. J Clin Virol. 2014;61:321–8.
    1. Paixao ES, Teixeira MG, Costa Mda C, Rodrigues LC. Dengue during pregnancy and adverse fetal outcomes: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16:857–65.
    1. WHO Manual for the Standardized Investigation, Diagnosis and Management of the Infertile Male. WHO. 2000
    1. Bonde U, Joergensen JS, Mogensen O, Lamont RF. The potential role of HPV vaccination in the prevention of infectious complications of pregnancy. Expert Rev Vaccines. 2014;13:1307–16.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다